美银证券:重申阿里健康“买入”评级 目标价4.6港元

智通财经
30 Dec 2024

智通财经APP获悉,美银证券发布研究报告称,维持阿里健康(00241)目标价4.6港元,重申“买入”评级,且调升收入及纯利预测。该行归纳公司管理层言论指出,利润存在潜在上升空间,再投资支出亦较少;非药物业务亦见快速增长;直销收入及整体收入预计将于2025下半财年及2026财年增长加快。管理层也对2025、26财年收入及经调整纯利目标抱有信心。因此,该行上调公司2025财年收入预测至增长13%,维持...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10